Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

248 results
Display

Perioperative immunotherapy in stage IB-III non-small cell lung cancer: a critical review of its rationale and considerations

Sim JK, Choi J, Lee SY

Lung cancer is a dismal disease as a leading cause of overall cancer death, but the development of immune checkpoint inhibitors (ICIs) in driver gene mutation negative metastatic non-small cell...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antimetastatic effect of fucoidan against non-small cell lung cancer by suppressing non-receptor tyrosine kinase and extracellular signalrelated kinase pathway

Muneerungsee N, Tanasawet S, Sukketsiri W

BACKGROUND/OBJECTIVES: Fucoidan, a polysaccharide content in brown algae, has been reported to inhibit the growth of cancer cells. The present study aimed to investigate the suppression effects of fucoidan on...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Subtype-Based Microbial Analysis in Non-small Cell Lung Cancer

Jang HJ, Lee E, Cho YJ, Lee SH

Background: The human lung serves as a niche for a unique and dynamic bacterial community related to the development and aggravation of multiple respiratory diseases. Therefore, identifying the microbiome status...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Exploring the past, present, and future of postoperative radiotherapy for N2 stage non-small cell lung cancer

Kim BH, Kim JS, Kim HJ

Despite conventionally applied postoperative radiotherapy (PORT) in pathological N2 (pN2) stage non-small cell lung cancer (NSCLC) considering high locoregional recurrence, its survival benefit has been a continuous topic of debate....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combination of the LARS1 Inhibitor, BC-LI-0186 with a MEK1/2 Inhibitor Enhances the Anti-Tumor Effect in Non–Small Cell Lung Cancer

Lee SH, Kim EY, Han JM, Han G, Chang YS

Purpose The mammalian target of rapamycin complex 1 (mTORC1) regulates cell growth and proliferation by growth factor coordination and amino acid availability. Leucyl-tRNA synthetase 1 (LARS1) senses the intracellular leucine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnostic Performance of Endosonography to Detect Mediastinal Lymph Node Metastasis in Patients with Radiological N1 Non–Small Cell Lung Cancer

Kim BG, Cho JH, Shin SH, Lee K, Um SW, Kim H, Kim J, Shim YM, Jeong BH

Purpose Guidelines recommend that non–small cell lung cancer (NSCLC) patients with suspected hilar lymph node (LN) metastases should undergo invasive mediastinal LN staging prior to surgical treatment via endosonography. We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Genomic Characteristics and the Potential Clinical Implications in Oligometastatic Non–Small Cell Lung Cancer

Liao R, Chen K, Li J, He H, Yi G, Huang M, Chen R, Shen L, Zhang X, Xu Z, Yang Z, Peng Y

Purpose Oligometastatic non–small cell lung cancer (NSCLC) patients have been increasingly regarded as a distinct group that could benefit from local treatment to achieve a better clinical outcome. However, current...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Picropodophyllotoxin Inhibits Cell Growth and Induces Apoptosis in Gefitinib-Resistant Non-Small Lung Cancer Cells by Dual-Targeting EGFR and MET

Lee JY, Kang BY, Jung SJ, Kwak AW, Lee SO, Park JW, Joo SH, Yoon G, Lee MH, Shim JH

Patients with non-small-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) amplification or sensitive muta-tions initially respond to the tyrosine kinase inhibitor gefitinib, however, the treatment becomes less effective...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer

Lee JH, Kim EY, Park CK, Lee SY, Lee Mk, Yoon SH, Lee JE, Lee SH, Kim SJ, Lee SY, Lim JH, Jang TW, Jang SH, Lee KY, Lee SH, Yang SH, Park DW, Park CK, Kang HS, Yeo CD, Choi CM, Lee JC

Purpose Although osimertinib is the standard-of-care treatment of epidermal growth factor receptor (EGFR) T790M mutation–positive non–small cell lung cancer, real-world evidence on the efficacy of osimertinib is not enough to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lazertinib: on the Way to Its Throne

Lee J, Hong MH, Cho BC

Lazertinib is an oral, irreversible, third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that forms an irreversible covalent bond to the Cys797 residue in the ATP-binding site of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer Patients with Liver Metastases: A Network Meta-Analysis of Nine Randomized Controlled Trials

Yin Q, Dai L, Sun R, Ke P, Liu L, Jiang B

Purpose This network meta-analysis (NMA) was conducted to compare the efficacy of immune checkpoint inhibitors in advanced non–small cell lung cancer (NSCLC) patients with liver metastases. Materials and Methods English literature...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Optimal positive lymph node ratio showing the benefit of postoperative radiotherapy in pathologic N2 non-small cell lung cancer: an exploratory study using the Surveillance, Epidemiology, and End Results data

Lee S, Noh OK

Purpose: This study aimed to identify the clinical parameters having the beneficial effect of postoperative radiotherapy (PORT) in pathologic N2 (pN2) non-small cell lung cancer (NSCLC) using the Surveillance, Epidemiology,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
ABT-737, a BH3 Mimetic, Enhances the Therapeutic Effects of Ionizing Radiation in K-ras Mutant Non-Small Cell Lung Cancer Preclinical Model

Lee JM, Kim HS, Kim A, Chang YS, Lee JG, Cho J, Kim EY

Purpose: Tumor radioresistance and dose-limiting toxicity restrict the curative potential of radiotherapy, requiring novel approaches to overcome the limitations and augment the efficacy. Here, we investigated the effects of signal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Guidelines for the Investigation and Management of Ground Glass Nodules

Lee JH, Hong JI, Kim HK

The clinical significance of ground-glass nodules (GGNs) has been investigated in extensive clinical research for many years. The natural history of GGNs is known to be closely related to their...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacokinetic properties and bioequivalence of gefitinib 250 mg in healthy Korean male subjects

Moon SJ, Kim Y, Jeon JY, Park SJ, Kwak YG, Kim MG

Gefitinib is an anti-cancer drug used to treat non-small cell lung cancer. The objective of this study was to compare the pharmacokinetics and evaluate the bioequivalence of 2 orally administered...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Salvage radiation therapy for postoperative locoregionally recurrent non-small cell lung cancer: a single-center experience

Jo YY, Kim SS, Song SY, Choi EK

Purpose: To determine the effectiveness of salvage radiation therapy (RT) in patients with locoregional recurrence (LRR) following initial curative resection of non-small cell lung cancer (NSCLC) and identify the prognostic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Robot-Assisted Thoracic Surgery in Non-small Cell Lung Cancer

Lee JH, Hong JI, Kim HK

Lobectomy is the standard treatment for early non-small cell lung cancer. Various surgical techniques for lobectomy have been developed, and minimally invasive thoracic surgery, such as video-assisted thoracic surgery or...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Temporal evolution of programmed death-ligand 1 expression in patients with non-small cell lung cancer

Nam CH, Koh J, Ock CY, Kim M, Keam B, Kim TM, Jeon YK, Kim DW, Chung DH, Heo DS

Background/Aims: Programmed death-ligand 1 (PD-L1) expression, a validated predictive biomarker for anti-PD-1/PD-L1 inhibitors, is reported to change over time. This poses challenges during clinical application in non-small cell lung cancer. Methods:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Surgical Impacts of Metastatic Nonsmall Cell Lung Cancer to the Thoracic and Lumbar Spine

Jung Jm, Hyun SJ, Kim KJ

Background: Surgery for spinal metastasis is rapidly increasing in frequency with procedures ranging from laminectomy to spondylectomy combined with stabilization. This study investigated the effect of various surgical procedures for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rapidly Destructive Arthrosis of Knee Following Treatment of Crizotinib in a Patient with Non-Small-Cell Lung Cancer

Hwang JT, Choi JH, Park CH, Yoon KJ, Lee YT, Do JG

Rapidly destructive arthrosis is a rare syndrome characterized by narrowing of the joint space and rapid joint destruction within 6∼12 months. A 62-year-old woman with anaplastic lymphoma kinase rearranged non-small-cell...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr